AMPE News and Press, Ampio Pharmaceuticals Inc. From 08/04/21

Ampio Pharmaceuticals, Inc. (AMPE) Q2 2021 Earnings Conference Call August 4, 2021 04:30 PM ET Company Participants Dan Stokely - Chief Financial Officer Mike Macaluso - Chairman & Chief Executive Officer Holli Cherevka - Chief Operating Officer David Bar-Or - Director & Founder Confe...

Ampio Pharmaceuticals, Inc. Announces Second Quarter 2021 Financial Results and Provides Corporate Update Further details to be discussed on this afternoon's conference call PR Newswire ENGLEWOOD, Colo. , Aug. 4, 2021 /PRNewswire/ -- Ampio Pharmaceutical...

Ampio Pharmaceuticals to Present at the American College of Toxicology 42nd Annual Meeting PR Newswire ENGLEWOOD, Colo. , July 29, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of ...

Ampio Pharmaceuticals to Present at the 14th International Congress on Systemic Lupus Erythematosus (LUPUS 2021) & 6th International Congress on Controversies in Rheumatology and Autoimmunity (CORA) Ampio Pharmaceuticals to Present at the 14th International Congress on Syste...

Ampio Pharmaceuticals to Present at Aspen Lung Conference Virtual poster session will highlight strong positive results from the Phase I trial using inhaled Ampion™ for treating COVID-19 patients PR Newswire ENGLEWOOD, Colo. , July 27, 2021 /PRNewswire...

Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 Second Quarter Financial Results and Provide Corporate Business Update PR Newswire ENGLEWOOD, Colo. , July 14, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company foc...

7 Biotech Penny Stocks to Watch in Summer 2021 With Summer well underway, biotech penny stocks are heating up. Although the pandemic was responsible for the major biotech rally we witnessed last year, now, investors seem to be focused on these penny stocks regardless of their involv...

Ampio Pharmaceuticals Announces Patient Randomization and Dosing in AP-019 Phase II Study of Inhaled Ampion in COVID-19 Respiratory Distress PR Newswire ENGLEWOOD, Colo. , June 25, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a bi...

Ampio Pharmaceuticals, Inc. to Join the Russell 2000® Index and Russell 3000® Index PR Newswire ENGLEWOOD, Colo. , June 18, 2021 /PRNewswire/ – Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical co...

Ampio Pharmaceuticals ([[AMPE]] +1.4%) posts newly integrated data from four of its earlier clinical trials utilizing the company's Ampion treatment for treating osteoarthritis of the knee ((OAK)).The pooled data showed a reduction in pain of 34.3% at two weeks (compared to 28.6% fo...